BOTHELL, Wash., March 6 /PRNewswire-FirstCall/ -- Cardiac Science
Corporation (Nasdaq: CSCX), a global leader in advanced cardiac diagnosis,
resuscitation, rehabilitation, and informatics products, announced today that
it aligned the power of its leading product brands (Burdick(R),
HeartCentrix(R), Powerheart(R), and Quinton(R)), squarely behind the Cardiac
Science(TM) brand.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGO)
"We believe our solitary focus on noninvasive cardiology elevates our
product and service offerings and differentiates us in the medical devices
field," said John Hinson, Cardiac Science president and chief executive
officer. "Going forward, our 95-year heritage and track record, comprehensive
product and service offerings, and the strengths of our predecessor companies
will be concentrated into a single, overarching story of dependability."
"Our products, employees, and culture are rooted in dependability," began
Allan Criss, senior vice president of sales, marketing, and service. "The new
Cardiac Science identity communicates our promise more clearly: We intend to
be the company the global community thinks of first for high-quality
noninvasive products and services. Our customers can -- and do -- depend on
us, no matter what."
The new "shielded heart" logo represents the protective nature of the
business. Cardiac Science products diagnose heart disease, resuscitate victims
of sudden cardiac arrest, and help people get on with their lives with
top-of-the-line cardiac rehabilitative equipment. The orange color represents
the warmth, energy, and approachability of the brand.
"The company is dependable. Their products -- their treadmills, stress
systems, ECG devices, connectivity, computer telemetry, printing mechanisms,
and more -- the whole apparatus works well together," said Dr. Diana
Westerfield, D.O., chief of staff, Barnes-Jewish St. Peter's Hospital in St.
Peter's, MO, and member of the Missouri Advisory Committee for the Prevention
of Heart Disease and Stroke. "I just don't see the Cardiac Science stuff break
down. And if there is an issue, the Cardiac Science folks show up
quickly -- more so than other companies we deal with."
The company issued a corporate brochure
(http://www.cardiacscience.com/pdf/080201CSCBrochure.pdf), now available for
download on its website, to clearly explain the benefits of its products and
services.
Tony Titus, Cardiac Science vice president of marketing, said, "We believe
the new brand initiative will strengthen our marketing and save the company
money by consolidating our efforts. We expect to raise overall awareness of
the Cardiac Science brand, our unique offerings, and expect to increase sales
and goodwill among our customers."
About Cardiac Science
Cardiac Science develops, manufactures, and markets a family of advanced
diagnostic and therapeutic cardiology devices and systems, including automated
external defibrillators (AEDs), electrocardiograph devices (ECGs), cardiac
stress systems and treadmills, Holter monitoring systems, hospital
defibrillators, cardiac rehabilitation telemetry systems, and cardiology data
management systems (informatics) that connect with hospital information (HIS),
electronic medical record (EMR), and other information systems. The Company
sells a variety of related products and consumables, and provides a portfolio
of training, maintenance, and support services. Cardiac Science, the successor
to the cardiac businesses that established the trusted Burdick(R),
HeartCentrix(R), Powerheart(R), and Quinton(R) brands, is headquartered in
Bothell, Washington. With customers in more than 100 countries worldwide, the
company has operations in North America, Europe, and Asia. For information,
call 425.402.2000 or visit http://www.cardiacscience.com.
Forward Looking Statements
This press release contains forward-looking statements. These statements
and their underlying assumptions involve a number of risks and uncertainties
and are not guarantees of future performance. These are forward-looking
statements for purposes of the safe harbor provisions under the Private
Securities Litigation Reform Act of 1995. The words "believe," "expect,"
"intend," anticipate," variations of such words, and similar expressions
identify forward-looking statements, but their absence does not mean that the
statement is not forward looking. Actual results may vary significantly from
the results expressed or implied in such statements. Factors that could cause
or contribute to such varying results and other risks include the risk that
the Company's new branding initiative may not result in more effective
marketing, or increase sales, of the Company's products and services and may
not save the Company money, as well as other risks that are more fully
described in the Annual Report on Form 10-K filed by Cardiac Science
Corporation for the year ended December 31, 2006. Cardiac Science Corporation
undertakes no duty or obligation to update the information provided herein.
Company Contact: Investor Contact: Media Contact:
Mike Matysik Jenifer Kirtland Christopher Gale
Cardiac Science Corporation EVC Group, Inc. EVC Group, Inc.
Sr. Vice President and CFO (415) 896-6820 (201) 646-5431
(425) 402-2009 (203) 570-4681
cgale@evcgroup.com
SOURCE Cardiac Science Corporation
Company, Mike Matysik, Sr. Vice President and CFO of Cardiac Science
Corporation, +1-425-402-2009; Investor, Jenifer Kirtland, +1-415-896-6820,
Media, Christopher Gale, +1-201-646-5431, +1-203-570-4681, cgale@evcgroup.com,
both of EVC Group, Inc., for Cardiac Science Corporation
